Screener
CRISPR Therapeutics CRSP Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from CRISPR Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: CRISPR Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:48 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204188
FAQ
- What is CRISPR Therapeutics's price / book?
- CRISPR Therapeutics (CRSP) reported price / book of 2.5× in Q1 2026.
- How has CRISPR Therapeutics's price / book changed year-over-year?
- CRISPR Therapeutics's price / book increased by 57.7% year-over-year, from 1.6× to 2.5×.
- What is the long-term trend for CRISPR Therapeutics's price / book?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's price / book has grown at a -18.1% compound annual growth rate (CAGR), from 7× to 2.6×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about CRISPR Therapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude